Skip to main content

Scienture Holdings, Inc.

SCNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001382574

No open-market purchases or sales by Scienture Holdings, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $709.1K in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Scienture Holdings, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of SCNX: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders1512−3
Shares1.11M509.2K−604.3K (−54.3%)
Value$5.83M$2.25M−$3.58M (−61.4%)

New holders (4)

Institutions that held Scienture Holdings, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to SCNX in Q2 2021
InstitutionSharesValue% of portfolio
Vanguard Group Inc138,631$613.0K0.00%
Two Sigma Securities, LLC27,457$121.0K0.03%
Virtu Financial LLC21,217$94.0K0.01%
Blueshift Asset Management, LLC13,354$59.0K0.00%

Sold out (7)

Institutions that held Scienture Holdings, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of SCNX in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
Heartland Advisors Inc249,200$1.31M
Steward Partners Investment Advisory, LLC241,200$1.26M
Perritt Capital Management Inc135,481$710.0K
Renaissance Technologies LLC110,700$580.0K
G2 Investment Partners Management LLC10,000$52.0K
International Assets Investment Management, LLC5,500$29.0K
The PNC Financial Services Group, Inc.1,030$5.00K